Introduction to Lenacapavir On September 24, 2025, a landmark agreement was reached to bring the groundbreaking HIV prevention tool, injectable lenacapavir, to 120 low- and middle-income countries (LMICs) at an astonishing cost of just $40 per year. This partnership between Dr. Reddy’s Laboratories, Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI marks a…